Literature DB >> 18845279

Bone density, strength, and formation in adult cathepsin K (-/-) mice.

B Pennypacker1, M Shea, Q Liu, P Masarachia, P Saftig, S Rodan, G Rodan, D Kimmel.   

Abstract

Cathepsin K (CatK) is a cysteine protease expressed predominantly in osteoclasts, that plays a prominent role in degrading Type I collagen. Growing CatK null mice have osteopetrosis associated with a reduced ability to degrade bone matrix. Bone strength and histomorphometric endpoints in young adult CatK null mice aged more than 10 weeks have not been studied. The purpose of this paper is to describe bone mass, strength, resorption, and formation in young adult CatK null mice. In male and female wild-type (WT), heterozygous, and homozygous CatK null mice (total N=50) aged 19 weeks, in-life double fluorochrome labeling was performed. Right femurs and lumbar vertebral bodies 1-3 (LV) were evaluated by dual-energy X-ray absorptiometry (DXA) for bone mineral content (BMC) and bone mineral density (BMD). The trabecular region of the femur and the cortical region of the tibia were evaluated by histomorphometry. The left femur and sixth lumbar vertebral body were tested biomechanically. CatK (-/-) mice show higher BMD at the central and distal femur. Central femur ultimate load was positively influenced by genotype, and was positively correlated with both cortical area and BMC. Lumbar vertebral body ultimate load was also positively correlated to BMC. Genotype did not influence the relationship of ultimate load to BMC in either the central femur or vertebral body. CatK (-/-) mice had less lamellar cortical bone than WT mice. Higher bone volume, trabecular thickness, and trabecular number were observed at the distal femur in CatK (-/-) mice. Smaller marrow cavities were also present at the central femur of CatK (-/-) mice. CatK (-/-) mice exhibited greater trabecular mineralizing surface, associated with normal volume-based formation of trabecular bone. Adult CatK (-/-) mice have higher bone mass in both cortical and cancellous regions than WT mice. Though no direct measures of bone resorption rate were made, the higher cortical bone quantity is associated with a smaller marrow cavity and increased retention of non-lamellar bone, signs of decreased endocortical resorption. The relationship of bone strength to BMC does not differ with genotype, indicating the presence of bone tissue of normal quality in the absence of CatK.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845279     DOI: 10.1016/j.bone.2008.08.130

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  43 in total

1.  Study of the mechanisms by which Sambucus williamsii HANCE extract exert protective effects against ovariectomy-induced osteoporosis in vivo.

Authors:  Y Zhang; Q Li; H-Y Wan; H-H Xiao; W-P Lai; X-S Yao; M-S Wong
Journal:  Osteoporos Int       Date:  2010-04-23       Impact factor: 4.507

Review 2.  New treatment modalities in osteoporosis.

Authors:  Ernesto Canalis
Journal:  Endocr Pract       Date:  2010 Sep-Oct       Impact factor: 3.443

3.  Combination therapy with ONO-KK1-300-01, a cathepsin K inhibitor, and parathyroid hormone results in additive beneficial effect on bone mineral density in ovariectomized rats.

Authors:  Yasuo Ochi; Hiroyuki Yamada; Hiroshi Mori; Naoki Kawada; Makoto Tanaka; Akira Imagawa; Kazuyuki Ohmoto; Kazuhito Kawabata
Journal:  J Bone Miner Metab       Date:  2015-03-12       Impact factor: 2.626

4.  Interferon Gamma-1b Does Not Increase Markers of Bone Resorption in Autosomal Dominant Osteopetrosis.

Authors:  Erik A Imel; Ziyue Liu; Dena Acton; Melissa Coffman; Netsanet Gebregziabher; Yan Tong; Michael J Econs
Journal:  J Bone Miner Res       Date:  2019-05-13       Impact factor: 6.741

Review 5.  Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis.

Authors:  Aline G Costa; Natalie E Cusano; Barbara C Silva; Serge Cremers; John P Bilezikian
Journal:  Nat Rev Rheumatol       Date:  2011-06-14       Impact factor: 20.543

6.  Generation of fertile and fecund F0 XY female mice from XY ES cells.

Authors:  Junko Kuno; William T Poueymirou; Guochun Gong; Chia-Jen Siao; Georgia Clarke; Lakeisha Esau; Nada Kojak; Julita Posca; Amanda Atanasio; John Strein; George D Yancopoulos; Ka-Man Venus Lai; Thomas M DeChiara; David Frendewey; Wojtek Auerbach; David M Valenzuela
Journal:  Transgenic Res       Date:  2014-08-03       Impact factor: 2.788

7.  Cathepsin K-deficient osteocytes prevent lactation-induced bone loss and parathyroid hormone suppression.

Authors:  Sutada Lotinun; Yoshihito Ishihara; Kenichi Nagano; Riku Kiviranta; Vincent T Carpentier; Lynn Neff; Virginia Parkman; Noriko Ide; Dorothy Hu; Pamela Dann; Daniel Brooks; Mary L Bouxsein; John Wysolmerski; Francesca Gori; Roland Baron
Journal:  J Clin Invest       Date:  2019-05-21       Impact factor: 14.808

8.  Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.

Authors:  Sutada Lotinun; Riku Kiviranta; Takuma Matsubara; Jorge A Alzate; Lynn Neff; Anja Lüth; Ilpo Koskivirta; Burkhard Kleuser; Jean Vacher; Eero Vuorio; William C Horne; Roland Baron
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

9.  Autophagy in osteoblasts is involved in mineralization and bone homeostasis.

Authors:  Marie Nollet; Sabine Santucci-Darmanin; Véronique Breuil; Rasha Al-Sahlanee; Chantal Cros; Majlinda Topi; David Momier; Michel Samson; Sophie Pagnotta; Laurence Cailleteau; Séverine Battaglia; Delphine Farlay; Romain Dacquin; Nicolas Barois; Pierre Jurdic; Georges Boivin; Dominique Heymann; Frank Lafont; Shi Shou Lu; David W Dempster; Georges F Carle; Valérie Pierrefite-Carle
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

10.  Odanacatib, a new drug for the treatment of osteoporosis: review of the results in postmenopausal women.

Authors:  José Luis Pérez-Castrillón; Florentino Pinacho; Daniel De Luis; María Lopez-Menendez; Antonio Dueñas Laita
Journal:  J Osteoporos       Date:  2010-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.